Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-19-012916

Options or other derivatives

  • Chief R&D Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cavanagh William Chief R&D Officer 2019-06-18 Grant or award · Stock Options (right to buy) +150,000 551,660 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…